Russell Investments Group’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.41M | Buy |
51,046
+11,458
| +29% | +$589K | ﹤0.01% | 1971 |
|
|
2026
Q1 | $2.35M | Buy |
39,588
+5,467
| +16% | +$355K | ﹤0.01% | 1796 |
|
|
2025
Q4 | $2.1M | Buy |
34,121
+1
| +0% | +$61 | ﹤0.01% | 1836 |
|
|
2025
Q3 | $2.13M | Buy |
34,120
+6,569
| +24% | +$457K | ﹤0.01% | 1818 |
|
|
2025
Q2 | $2.2M | Sell |
27,551
-564
| -2% | -$47.2K | ﹤0.01% | 1675 |
|
|
2025
Q1 | $2.42M | Buy |
28,115
+561
| +2% | +$46K | ﹤0.01% | 1579 |
|
|
2024
Q4 | $2.15M | Sell |
27,554
-954
| -3% | -$74.1K | ﹤0.01% | 1634 |
|
|
2024
Q3 | $2.06M | Buy |
28,508
+1,945
| +7% | +$138K | ﹤0.01% | 1679 |
|
|
2024
Q2 | $1.83M | Buy |
26,563
+47
| +0.2% | +$3.18K | ﹤0.01% | 1687 |
|
|
2024
Q1 | $1.92M | Sell |
26,516
-2,038
| -7% | -$136K | ﹤0.01% | 1669 |
|
|
2023
Q4 | $1.75M | Sell |
28,554
-6,888
| -19% | -$409K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $2.03M | Sell |
35,442
-2,691
| -7% | -$163K | ﹤0.01% | 1531 |
|
|
2023
Q2 | $2.27M | Buy |
38,133
+273
| +0.7% | +$16.3K | ﹤0.01% | 1481 |
|
|
2023
Q1 | $2.37M | Sell |
37,860
-4,711
| -11% | -$294K | ﹤0.01% | 1476 |
|
|
2022
Q4 | $2.68M | Sell |
42,571
-29,619
| -41% | -$1.7M | 0.01% | 1409 |
|
|
2022
Q3 | $3.61M | Sell |
72,190
-5,876
| -8% | -$325K | 0.01% | 1238 |
|
|
2022
Q2 | $4.51M | Sell |
78,066
-3,596
| -4% | -$198K | 0.01% | 1154 |
|
|
2022
Q1 | $4.34M | Buy |
81,662
+15,778
| +24% | +$911K | 0.01% | 1239 |
|
|
2021
Q4 | $4.05M | Sell |
65,884
-748
| -1% | -$44.4K | 0.01% | 1378 |
|
|
2021
Q3 | $3.77M | Sell |
66,632
-39,567
| -37% | -$2.17M | 0.01% | 1420 |
|
|
2021
Q2 | $5.54M | Sell |
106,199
-81,134
| -43% | -$3.9M | 0.01% | 1281 |
|
|
2021
Q1 | $8.22M | Buy |
187,333
+52,341
| +39% | +$2.2M | 0.01% | 1066 |
|
|
2020
Q4 | $4.72M | Sell |
134,992
-157,513
| -54% | -$5.59M | 0.01% | 1265 |
|
|
2020
Q3 | $10.5M | Sell |
292,505
-127,874
| -30% | -$4.76M | 0.02% | 740 |
|
|
2020
Q2 | $15.6M | Buy |
420,379
+51,775
| +14% | +$2.07M | 0.03% | 553 |
|
|
2020
Q1 | $13.6M | Sell |
368,604
-30,571
| -8% | -$1.19M | 0.04% | 525 |
|
|
2019
Q4 | $16.3M | Buy |
399,175
+3,066
| +0.8% | +$114K | 0.03% | 627 |
|
|
2019
Q3 | $13.7M | Buy |
396,109
+53,620
| +16% | +$1.77M | 0.03% | 708 |
|
|
2019
Q2 | $10.7M | Buy |
342,489
+70,769
| +26% | +$2.1M | 0.02% | 848 |
|
|
2019
Q1 | $8.11M | Buy |
271,720
+3,296
| +1% | +$94.5K | 0.02% | 995 |
|
|
2018
Q4 | $8.25M | Sell |
268,424
-14,373
| -5% | -$524K | 0.02% | 908 |
|
|
2018
Q3 | $10.8M | Sell |
282,797
-18,713
| -6% | -$708K | 0.02% | 896 |
|
|
2018
Q2 | $11.6M | Sell |
301,510
-209,141
| -41% | -$7.05M | 0.02% | 824 |
|
|
2018
Q1 | $17.2M | Buy |
510,651
+221,811
| +77% | +$8.51M | 0.03% | 692 |
|
|
2017
Q4 | $12.9M | Buy |
288,840
+32,172
| +13% | +$1.47M | 0.02% | 849 |
|
|
2017
Q3 | $12.9M | Buy |
256,668
+56,001
| +28% | +$2.86M | 0.02% | 825 |
|
|
2017
Q2 | $10.6M | Sell |
200,667
-52,909
| -21% | -$2.84M | 0.02% | 889 |
|
|
2017
Q1 | $14.1M | Buy |
253,576
+98,309
| +63% | +$5.42M | 0.03% | 711 |
|
|
2016
Q4 | $8.09M | Buy |
+155,267
| New | +$7.49M | 0.02% | 968 |
|
Other funds holding PBH
AI
BIP
Russell Investments Group's PBH Position: Q2 2026 in Review
Russell Investments Group increased its Prestige Consumer Healthcare (PBH) stake by 29% in Q2 2026, buying an estimated $589K and bringing the position to 51,046 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.
Russell Investments Group first reported a position in PBH in Q4 2016 and has held it in 39 quarters since. The position peaked at $17.2M in Q1 2018. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Russell Investments Group held 51,046 shares of Prestige Consumer Healthcare worth $2.41M as of Q2 2026.
- Russell Investments Group bought 11,458 Prestige Consumer Healthcare shares in Q2 2026, an estimated $589K.
- Prestige Consumer Healthcare made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1971 holding.
- Russell Investments Group first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's Prestige Consumer Healthcare position peaked at $17.2M in Q1 2018.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.